Skip to main content
FinSpry Logo
FinSpry
ONC logo
ONC
(NASDAQ)
BeOne Medicines AG
$310.79-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

BeOne Medicines (ONC) Stock Price & Financial Analysis

BeOne Medicines Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$306.33 - $315.97
52-Week High$385.22
52-Week Low$196.45
Open$307.42
Volume133.47K
Average Volume (3M)133.47K
Market Cap35.26B
Shares Outstanding113.45M
P/E Ratio (TTM)121.95
Price to Sales (P/S)6.55
Price to Book (P/B)8.02
EV/EBITDA41.31
Revenue (TTM)5.34B
Net Income (TTM)286.93M
Free Cash Flow (TTM)612.50M
EPS (TTM)$2.53
Profit Margin5.37%
Operating Margin8.37%
Return on Equity (ROE)6.58%
Debt to Equity0.46
50-Day MA$321.34
200-Day MA$314.92
52-Week Change13.80%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About BeOne Medicines

What is the current stock price for ONC?

As of the latest trading session, ONC stock trades at $310.79. The 52-week range is $196.45–$385.22, with a day range of $306.32–$315.97.

What is the P/E ratio for ONC?

BeOne Medicines's trailing P/E ratio is 122.0, meaning investors pay $122.0 for every $1 of annual earnings. BeOne Medicines operates in the Healthcare sector.

Does ONC pay dividends?

BeOne Medicines does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ONC?

Based on 6 analysts, the consensus for ONC is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ONC?

BeOne Medicines's market capitalization is $35.26B, classifying it as a large-cap company. BeOne Medicines operates in the Healthcare sector within the Biotechnology industry.